| Quarterly Financial Information [Text Block] |
| 18. |
Supplemental Financial Information |
Quarterly Results of Operations (Unaudited)
The following tables present the unaudited statements of operations data for each of the eight quarters in the years ended December 31, 2020 and December 31, 2019. The information has been presented on the same basis as the audited financial statements and all necessary adjustments, consisting only of normal recurring adjustments, have been included in the amounts below to present fairly the unaudited quarterly results when read in conjunction with the audited financial statements and related notes. The operating results for any quarter should not be relied upon as necessarily indicative of results for any future period.
Unaudited Quarterly Results of Operations
(in thousands, except share and per share amounts)
| |
|
Three months ended |
|
|
|
|
|
| |
|
March 31, 2020 |
|
|
June 30, 2020 |
|
|
September 30, 2020 |
|
|
December 31, 2020 |
|
|
Total for year 2020 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Product sales |
|
$ |
18 |
|
|
$ |
— |
|
|
$ |
90 |
|
|
|
— |
|
|
$ |
108 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Operating cost and expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cost of product sales |
|
|
1,454 |
|
|
|
1,306 |
|
|
|
1,635 |
|
|
|
1,081 |
|
|
|
5,476 |
|
| Research and development cost |
|
|
242 |
|
|
|
217 |
|
|
|
210 |
|
|
|
358 |
|
|
|
1,027 |
|
| General and administrative expense |
|
|
2,385 |
|
|
|
2,245 |
|
|
|
1,656 |
|
|
|
2,712 |
|
|
|
8,998 |
|
| Total operating expenses |
|
|
4,081 |
|
|
|
3,768 |
|
|
|
3,501 |
|
|
|
4,151 |
|
|
|
15,501 |
|
| Loss from operations |
|
|
(4,063 |
) |
|
|
(3,768 |
) |
|
|
(3,411 |
) |
|
|
(4,151 |
) |
|
|
(15,393 |
) |
| Other income and expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Insurance proceeds net of related expenses |
|
|
(203 |
) |
|
|
(52 |
) |
|
|
1,722 |
|
|
|
1,479 |
|
|
|
2,946 |
|
| Impairment expense |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(11,741 |
) |
|
|
(11,741 |
) |
| Interest expense |
|
|
(183 |
) |
|
|
(164 |
) |
|
|
(166 |
) |
|
|
(1,107 |
) |
|
|
(1,620 |
) |
| Interest and other income |
|
|
22 |
|
|
|
3 |
|
|
|
18 |
|
|
|
5 |
|
|
|
48 |
|
| Total other expense, net |
|
|
(364 |
) |
|
|
(213 |
) |
|
|
1,574 |
|
|
|
(11,364 |
) |
|
|
(10,367 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss before income tax expense |
|
|
(4,427 |
) |
|
|
(3,981 |
) |
|
|
(1,837 |
) |
|
|
(15,515 |
) |
|
|
(25,760 |
) |
| Income tax expense |
|
|
— |
|
|
|
(2 |
) |
|
|
— |
|
|
|
— |
|
|
|
(2 |
) |
| Net loss |
|
$ |
(4,427 |
) |
|
$ |
(3,983 |
) |
|
$ |
(1,837 |
) |
|
$ |
(15,515 |
) |
|
$ |
(25,762 |
) |
| Weighted average shares outstanding, basic and diluted |
|
|
59,582,603 |
|
|
|
60,136,374 |
|
|
|
60,998,971 |
|
|
|
62,136,421 |
|
|
|
60,861,450 |
|
| Basic and diluted net loss per share |
|
$ |
(0.07 |
) |
|
$ |
(0.07 |
) |
|
$ |
(0.03 |
) |
|
$ |
(0.25 |
) |
|
$ |
(0.42 |
) |
| |
|
Three months ended |
|
|
|
|
|
| |
|
March 31, 2019 |
|
|
June 30, 2019 |
|
|
September 30, 2019 |
|
|
December 31, 2019 |
|
|
Total for year 2019 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Product sales |
|
$ |
437 |
|
|
$ |
1,483 |
|
|
$ |
2,361 |
|
|
$ |
593 |
|
|
$ |
4,874 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Operating cost and expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cost of product sales |
|
|
4,681 |
|
|
|
7,185 |
|
|
|
8,231 |
|
|
|
4,702 |
|
|
|
24,799 |
|
| Research and development cost |
|
|
620 |
|
|
|
338 |
|
|
|
282 |
|
|
|
315 |
|
|
|
1,555 |
|
| General and administrative expense |
|
|
4,016 |
|
|
|
4,335 |
|
|
|
5,107 |
|
|
|
5,856 |
|
|
|
19,314 |
|
| Total operating expenses |
|
|
9,317 |
|
|
|
11,858 |
|
|
|
13,620 |
|
|
|
10,873 |
|
|
|
45,668 |
|
| Loss from operations |
|
|
(8,880 |
) |
|
|
(10,375 |
) |
|
|
(11,259 |
) |
|
|
(10,280 |
) |
|
|
(40,794 |
) |
| Other income and expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Insurance proceeds net of related expenses |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(792 |
) |
|
|
(792 |
) |
| Interest expense |
|
|
(2,889 |
) |
|
|
(203 |
) |
|
|
(142 |
) |
|
|
(243 |
) |
|
|
(3,477 |
) |
| Interest and other income |
|
|
63 |
|
|
|
77 |
|
|
|
85 |
|
|
|
45 |
|
|
|
270 |
|
| Total other expense, net |
|
|
(2,826 |
) |
|
|
(126 |
) |
|
|
(57 |
) |
|
|
(990 |
) |
|
|
(3,999 |
) |
| Loss before income tax expense |
|
|
(11,706 |
) |
|
|
(10,501 |
) |
|
|
(11,316 |
) |
|
|
(11,270 |
) |
|
|
(44,793 |
) |
| Income tax expense |
|
|
(2 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(2 |
) |
| Net loss |
|
$ |
(11,708 |
) |
|
$ |
(10,501 |
) |
|
$ |
(11,316 |
) |
|
$ |
(11,270 |
) |
|
$ |
(44,795 |
) |
| Weighted average shares outstanding, basic and diluted |
|
|
43,514,225 |
|
|
|
50,757,448 |
|
|
|
57,053,982 |
|
|
|
57,523,283 |
|
|
|
52,263,885 |
|
| Basic and diluted net loss per share |
|
$ |
(0.27 |
) |
|
$ |
(0.21 |
) |
|
$ |
(0.20 |
) |
|
$ |
(0.20 |
) |
|
$ |
(0.86 |
) |
|